Mayo Clinic’s Black Stone Minerals BSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-166,147
Closed -$2.86M 8
2023
Q3
$2.86M Sell
166,147
-477,470
-74% -$8.14M 5.52% 3
2023
Q2
$10.3M Hold
643,617
10.54% 2
2023
Q1
$10.1M Hold
643,617
8.29% 2
2022
Q4
$10.9M Buy
+643,617
New +$11.4M 5.75% 2
2021
Q2
$52.5M Sell
4,879,824
-840,100
-15% -$8.47M 58.01% 1
2021
Q1
$49.9M Hold
5,719,924
57.43% 1
2020
Q4
$38.2M Hold
5,719,924
45.97% 1
2020
Q3
$35.1M Buy
5,719,924
+8,787
+0.2% +$58.6K 47.33% 1
2020
Q2
$37.1M Hold
5,711,137
35.52% 1
2020
Q1
$26.7M Buy
5,711,137
+13,389
+0.2% +$123K 67.58% 1
2019
Q4
$72.5M Buy
+5,697,748
New +$72.6M 82.19% 1

Other funds holding BSM

Mayo Clinic's BSM Position: Q4 2023 in Review

Mayo Clinic sold out of Black Stone Minerals (BSM) in Q4 2023, closing a stake of 166,147 shares — an estimated $2.86M sold.

Mayo Clinic first reported a position in BSM in Q4 2019 and held it in 11 quarters. The position peaked at $72.5M in Q4 2019. 195 funds tracked by Wall St. Rank hold BSM as of Q4 2023.

  • Mayo Clinic reported no remaining Black Stone Minerals position as of Q4 2023 after selling out during the quarter.
  • Mayo Clinic sold 166,147 Black Stone Minerals shares in Q4 2023, an estimated $2.86M.
  • Mayo Clinic first reported a position in Black Stone Minerals in Q4 2019 and held it in 11 quarters.
  • Mayo Clinic's Black Stone Minerals position peaked at $72.5M in Q4 2019.
  • 195 funds tracked by Wall St. Rank held Black Stone Minerals as of Q4 2023.

Based on Mayo Clinic's 13F filing for Q4 2023, filed 13 Feb 2024.